Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

10-Year shoulder implant study aims to improve joint replacement outcomes

NCT ID NCT07558590

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows over 1,000 people who receive a shoulder replacement with FX Shoulder Solutions systems. Researchers will track how often the implant needs to be replaced (revision) and measure pain, movement, and quality of life for up to 10 years after surgery. The goal is to see how well these shoulder implants perform in everyday patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,004 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2020

Expected to finish

Jun 2037

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study population is issued from investigators' patient population.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Indication for hemi or total shoulder replacement with one of the FX SHOULDER SOLUTIONS Shoulder Systems, according to its IFU and surgical technique. * Patient aged 18 years and above * Patient insured with a social security system * Has been informed and did consent to participate to the study. Exclusion Criteria: * Neurological pathologies compromising the shoulder stability * Morbid obesity * Muscular deficiencies impairing the shoulder joint

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Avascular necrosis of the head of humerus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    22 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • C. H. St- Nazaire

    RECRUITING

    Saint-Nazaire, 44606, France

  • CHMS Chambéry

    RECRUITING

    Chambéry, 73011, France

  • CHU Amiens Picardie

    RECRUITING

    Amiens, 80054, France

  • CHU d' Angers

    RECRUITING

    Angers, 49933, France

  • Centre Hospitalier Princesse Grace

    RECRUITING

    Monaco, 98000, Monaco

  • Clinique Aguiléra

    RECRUITING

    Biarritz, 64200, France

  • Clinique Mutualiste

    RECRUITING

    Saint-Etienne, 42000, France

  • Clinique Saint Charles

    RECRUITING

    La Roche-sur-Yon, 85016, France

  • Clinique Saint Charles

    RECRUITING

    Lyon, 69001, France

  • Clinique Saint Michel et Sainte Anne

    RECRUITING

    Quimper, 29000, France

  • Clinique chirurgicale Porte Océane

    RECRUITING

    Les Sables-d'Olonne, 85101, France

  • Clinique de l'Orangerie

    RECRUITING

    Strasbourg, 67000, France

  • Clinique des Maussins

    RECRUITING

    Paris, 75020, France

  • Hopital Bichat

    RECRUITING

    Paris, 75018, France

  • HÔPITAUX CIVILS de Colmar

    RECRUITING

    Colmar, 68024, France

  • Hôpital Jean Minjoz

    RECRUITING

    Besançon, 25030, France

  • Hôpital privé Dijon Bourgogne

    RECRUITING

    Dijon, 21000, France

  • Hôpital privé Saint-Martin

    RECRUITING

    Caen, 14000, France

  • Infirmerie Protestante

    RECRUITING

    Caluire-et-Cuire, 69300, France

  • L'hôpital privé du confluent

    RECRUITING

    Nantes, 44277, France

  • Pavillon de la Mutualite

    RECRUITING

    Pessac, 33608, France

  • Polyclinique de l'Atlantique

    RECRUITING

    Saint-Herblain, 44819, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.